<SEC-DOCUMENT>0000950170-25-111319.txt : 20250826
<SEC-HEADER>0000950170-25-111319.hdr.sgml : 20250826
<ACCEPTANCE-DATETIME>20250826091405
ACCESSION NUMBER:		0000950170-25-111319
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		12
CONFORMED PERIOD OF REPORT:	20250826
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250826
DATE AS OF CHANGE:		20250826

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lineage Cell Therapeutics, Inc.
		CENTRAL INDEX KEY:			0000876343
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				943127919
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12830
		FILM NUMBER:		251252945

	BUSINESS ADDRESS:	
		STREET 1:		2173 SALK AVENUE
		STREET 2:		SUITE 200
		CITY:			CARLSBAD
		STATE:			CA
		ZIP:			92008
		BUSINESS PHONE:		5105213390

	MAIL ADDRESS:	
		STREET 1:		2173 SALK AVENUE
		STREET 2:		SUITE 200
		CITY:			CARLSBAD
		STATE:			CA
		ZIP:			92008

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIOTIME INC
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>lctx-20250826.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-08-25T17:14:04.4010+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:lctx="http://lineagecell.com/20250826" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_4d958781-5597-4984-ba56-9a1bfa2a7e1f" name="dei:EntityCentralIndexKey" contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec">0000876343</ix:nonNumeric><ix:nonNumeric id="F_2018aa5c-dfc3-4ce8-b376-d6895b3ce2b5" name="dei:AmendmentFlag" contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="lctx-20250826.xsd"/></ix:references><ix:resources><xbrli:context id="C_405e5aab-2417-4f78-a579-0c21252efeec"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000876343</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-08-26</xbrli:startDate><xbrli:endDate>2025-08-26</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="border-top:2.25pt double #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES<br/>SECURITIES AND EXCHANGE COMMISSION<br/></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><h2 style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d2516ab7-d089-495e-9ab4-12b2147e6ada" contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8-K</span></ix:nonNumeric></span></h2><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CURRENT REPORT</span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.398%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span><ix:nonNumeric id="F_84edddb2-57bc-46e3-9358-ddf8410c48ba" contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">August 26, 2025</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="margin-left:40%;font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:24pt;font-family:Times New Roman;"><ix:nonNumeric id="F_229ea4a3-a296-4427-bffa-750226ceb100" contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Lineage Cell Therapeutics, Inc.</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Exact name of Registrant as Specified in Its Charter)</span></p><p style="margin-left:40%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:20%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:20%;box-sizing:content-box;"/>
     <td style="width:18%;box-sizing:content-box;"/>
     <td style="width:41%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_27d43ffc-ca2e-4670-ba03-11d0ce6eec2e" contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">California</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_20f5b682-7e38-4dce-8858-3c55eb593ad2" contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">001-12830</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_b18faed1-b11d-4c33-b580-86df6978c488" contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">94-3127919</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(State or Other Jurisdiction<br/>of Incorporation)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Commission File Number)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(IRS Employer<br/>Identification No.)</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_f6bb2d38-fc7d-4f8d-87ee-961734a1d6f7" contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2173 Salk Avenue, Suite 200</span></ix:nonNumeric></span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_ac8c7c64-6166-4a2b-b215-0fdacbe8a3b2" contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Carlsbad</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_f8b87063-b235-4ac2-9882-5d710fccd451" contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">California</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_c3d24d27-79f0-41ad-89ae-29bd0cc116c8" contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">92008</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Address of Principal Executive Offices)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Zip Code)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.125in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.398%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Registrant&#8217;s Telephone Number, Including Area Code:</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_137c8332-f621-4e77-8b73-96b9988bf605" contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(442)</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_14865e5a-f414-40eb-a22d-3d814b0249bd" contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">287-8990</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"/>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.125in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span></p><p style="margin-left:40%;font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:3pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ad51223d-386c-46d1-8518-d55ced04fa03" contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a67c4072-f7db-4a4a-a3a4-a1e85fd75fdb" contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f00e07f0-0d76-49f8-8023-093c045f0295" contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_39aec429-baa1-4ecf-b8df-d005e445f063" contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:9pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:38%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:15%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:45%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><br/>Title of each class</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Trading<br/>Symbol(s)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><br/>Name of each exchange on which registered</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_88736698-20be-4168-b0d0-c8cf41041626" contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common shares</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_6f6fd0a8-fced-4212-8d0f-9b8f273d181a" contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">LCTX</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_98659eb3-d40e-4766-a92f-e63ff5c02dad" contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">NYSE American LLC</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8239;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8239;240.12b-2 of this chapter).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Emerging growth company </span><span style="font-size:10pt;"><ix:nonNumeric id="F_1c638b3c-f504-4fec-a1d7-607f2e175769" contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><h2 style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 7.01 Regulation FD Disclosure.</span></h2><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 26, 2025, Lineage Cell Therapeutics, Inc. (&#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;Company,&#8221; or &#8220;Lineage&#8221;) issued a press release announcing that it entered into a multi-year research collaboration agreement with William Demant Invest 2 Aps (&#8220;WDI&#8221;) to advance the preclinical development of Lineage&#8217;s auditory neuronal cell transplant program, ReSonance</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TM</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (ANPI), for the treatment of hearing loss. A copy of the press release is furnished as Exhibit 99.1 hereto.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information in this Item 7.01 and in Exhibit 99.1 to this report is being furnished and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and is not to be incorporated by reference into any filing of the registrant under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in any such filing, except as shall be expressly set forth by specific reference in such a filing.</span></p><h2 style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 8.01 Other Events.</span></h2><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 22, 2025, Lineage and WDI entered into a research collaboration agreement (the &#8220;RCA&#8221;) to advance the preclinical development of Lineage&#8217;s auditory neuronal cell transplant program, ReSonance (ANPI), for the treatment of hearing loss (the &#8220;Project&#8221;). WDI will fund up to $12 million in research collaboration costs over the approximate three-year term of the RCA. The main objective of the RCA is for the parties to complete a preclinical phase achieving readiness to potentially progress to human clinical trials under one or more separate clinical agreements, the terms of which would be negotiated in good faith before the expiration of the RCA.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All intellectual property owned by a party prior to the date of the RCA will remain their sole and exclusive property. The parties will jointly own all results, data, reports, know-how and patent(s) conceived or otherwise generated in the course of and resulting from the Project (the &#8220;Project Results&#8221;), other than discoveries or developments relating to Lineage's prioprietary platform technology.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If a party (the &#8220;abandoning party&#8221;) informs the other party (the &#8220;continuing party&#8221;) that it will not continue the research with the other party under a clinical agreement, the continuing party may purchase the abandoning party&#8217;s ownership interest in the intellectual property resulting from the Project for exploitation for the treatment of hearing loss and a license to the abandoning party&#8217;s background intellectual property to the extent necessary for such exploitation for an amount and on terms to be determined by the mutual agreement of the parties, and if such mutual agreement is not reached, by an independent third-party.</span></p><h2 style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></h2><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d) Exhibits.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:8.08%;box-sizing:content-box;"/>
     <td style="width:1.02%;box-sizing:content-box;"/>
     <td style="width:90.9%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:1.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit No.</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:1.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:1.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99.1</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="lctx-ex9_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Press release issued on August 26, 2025</span></a></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNATURES</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:6%;box-sizing:content-box;"/>
     <td style="width:42%;box-sizing:content-box;"/>
     <td style="width:6%;box-sizing:content-box;"/>
     <td style="width:46%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:4.3pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lineage Cell Therapeutics, Inc.</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 26, 2025</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">/s/ George A. Samuel III</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Title:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">George A. Samuel III<br/>General Counsel and Corporate Secretary</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-9.1
<SEQUENCE>2
<FILENAME>lctx-ex9_1.htm
<DESCRIPTION>EX-9.1
<TEXT>
<!-- DFIN ActiveDisclosure (SM) HTML Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2025-08-25T17:14:04.4145+00:00 --><!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html>
 <head>
  <title>EX-9.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img193828089_0.jpg" alt="img193828089_0.jpg" style="width:307px;height:63px;"></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">LINEAGE ANNOUNCES RESEARCH COLLABORATION WITH WILLIAM DEMANT INVEST TO DEVELOP RESONANCE</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#153;</font><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:8.040000000000001pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(ANP1) FOR HEARING LOSS</font><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:5.5pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x25cf;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Three-year term intended to advance preclinical development of ReSonance </font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:5.5pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x25cf;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Up to $12 million of development costs to be contributed by William Demant Invest</font></div></div><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CARLSBAD, CA &#x2013; August 26, 2025 </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">- </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Lineage Cell Therapeutics, Inc.</font></font><font style="color:#0563c1;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or &#x201c;off the shelf&#x201d;, cell therapies for serious neurological and ophthalmic conditions, today announced that it has entered into a research collaboration with and through an investment</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">from</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">William Demant Invest A/S</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (WDI). WDI is an evergreen investor and the holding company for William Demant Foundation&#x2019;s investment activities - a majority shareholder of the world-leading hearing healthcare company, Demant A/S.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The parties will jointly advance Lineage&#x2019;s auditory neuronal cell transplant, ReSonance (ANP1), for the treatment of hearing loss. The multi-year research collaboration covers preclinical development activities, including cell manufacturing, proof-of-concept studies, translational/functional models, delivery development, outcome measures, regulatory strategy, and market analysis, to support a potential IND/CTA filing. WDI will fund up to $12 million in research collaboration costs over the period, with development activities jointly conducted and managed by Lineage and scientists from Eriksholm Research Centre, part of Oticon A/S, which is a subsidiary of the Demant Group</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;ReSonance is our first internally-developed cell transplant program and highlights the efficiency and breadth of our technology platform. Over a short period of time and with a modest initial, incremental investment, we advanced the ANP1 product concept through successful manufacture of the desired cell type, generated new intellectual property, and advanced into initial preclinical testing. With this research contribution from WDI, which has a strong interest in hearing healthcare, we are taking the next step in the development of this exciting product candidate. This partnership will allow us to integrate the hearing loss research expertise of Eriksholm Research Centre with the manufacturing and cell transplant expertise of the Lineage team to explore the potential of a differentiated cell transplant, and position this therapy for initial clinical development,&#x201d; stated Brian Culley, Lineage CEO.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">According to the World Health Organization (WHO), nearly 2.5 billion people are expected to experience some degree of hearing loss by 2025, ranging from mild to moderate to profound. In severe-to-profound cases, the condition may involve loss of auditory nerve cells, potentially leading to auditory neuropathy and significant hearing impairment.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Hearing relies on a series of steps that convert sound waves in the air into electrical signals, which are then relayed by auditory nerve cells to the brain. Auditory neuropathy is a challenging hearing disorder in which the auditory nerve cells are damaged or lost, meaning that the communication pathway from the ear to the brain is disrupted. Currently, auditory neuropathy remains a significant challenge in audiology, and treatment options are limited. However, one treatment approach is cell-based therapy, which aims to replace lost or damaged auditory nerve cells. By repopulating the cochlea with functional, transplanted auditory neurons, this approach may restore hearing and enhance the effectiveness of a cochlear implant in certain individuals with severe-to-profound hearing loss.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">About William Demant Invest</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">William Demant Invest is an evergreen investor and the holding company for William Demant Foundation&#x2019;s investment activities, focusing on investments in listed companies. The current market value for all companies in the portfolio is around DKK 150 billion. Founded in 2004, William Demant Invest is wholly owned by William Demant Foundation with an identical Board of Directors. The main purpose of William Demant Foundation is to</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">secure and expand the hearing healthcare company Demant and to donate a share of its net income to charter-defined causes.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">About Eriksholm Research Centre</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Eriksholm Research Centre</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is part of Oticon A/S, a world leader in hearing healthcare and part of the Demant A/S group of companies. Eriksholm is committed to making audiological discoveries with the potential to significantly enhance end-user benefits in hearing healthcare. Eriksholm engages in close collaborations with world leading academic research institutions. By bringing experts together, Eriksholm is able to create mutually beneficial research synergies and open up new lines of inquiry in the broader research community.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">About Lineage Cell Therapeutics, Inc.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel, &#x201c;off-the-shelf,&#x201d; cell therapies to address unmet medical needs. Lineage&#x2019;s programs are based on its proprietary cell-based technology platform and associated development and manufacturing capabilities. From this platform, Lineage designs, develops, manufactures, and tests specialized human cells with anatomical and physiological functions similar or identical to cells found naturally in the human body. These cells are created by applying directed differentiation protocols to established, well-characterized, and self-renewing pluripotent cell lines. These protocols generate cells with characteristics associated with specific and desired developmental lineages. Cells derived from such lineages are transplanted into patients in an effort to replace or support cells that are absent or dysfunctional due to degenerative disease, aging, or traumatic injury, and to restore or augment the patient&#x2019;s functional activity. Lineage&#x2019;s neuroscience focused pipeline currently includes: (i) OpRegen</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> cell therapy, a retinal pigment epithelial cell therapy in Phase 2a development under a worldwide collaboration with Roche and Genentech, a member of the Roche Group, for the treatment of geographic atrophy secondary to age-related macular degeneration; (ii) OPC1, an oligodendrocyte progenitor cell therapy in Phase 1/2a development for the treatment of spinal cord injuries; (iii) ReSonance (ANP1), an auditory neuronal progenitor cell therapy for the potential treatment of auditory neuropathy; (iv) PNC1, a photoreceptor neural cell therapy for the potential treatment of vision loss due to photoreceptor dysfunction or damage; and (v) RND1, a novel hypoimmune induced pluripotent stem cell line being developed under a gene editing partnership. For more information, please visit </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">www.lineagecell.com</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> or follow the company on X/Twitter </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">@LineageCell</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Forward-Looking Statements</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Lineage cautions you that all statements, other than statements of historical facts, contained in this press release, are forward-looking statements. Forward-looking statements, in some cases, can be identified by terms such as &#x201c;believe,&#x201d; &#x201c;aim,&#x201d; &#x201c;may,&#x201d; &#x201c;will,&#x201d; &#x201c;estimate,&#x201d; &#x201c;continue,&#x201d; &#x201c;anticipate,&#x201d; &#x201c;design,&#x201d; &#x201c;intend,&#x201d; &#x201c;expect,&#x201d; &#x201c;could,&#x201d; &#x201c;can,&#x201d; &#x201c;plan,&#x201d; &#x201c;potential,&#x201d; &#x201c;predict,&#x201d; &#x201c;seek,&#x201d; &#x201c;should,&#x201d; &#x201c;would,&#x201d; &#x201c;contemplate,&#x201d; &#x201c;project,&#x201d; &#x201c;target,&#x201d; &#x201c;tend to,&#x201d; or the negative version of these words and similar expressions. Lineage&#x2019;s forward-looking statements are based upon its current expectations and beliefs and involve assumptions that may never materialize or may prove to be incorrect. Such statements include, but are not limited to, statements relating to: the benefits of the research collaboration agreement with WDI and its impact on advancing the ReSonance (ANP1) program, including through a potential IND/CTA filing. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Lineage&#x2019;s actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by the forward-looking statements in this press release, including, but not limited to, the following risks: that development activities, preclinical activities, and clinical trials of our product candidates may not commence, progress or be completed as expected due to many factors within and outside of our control; that positive findings in early clinical and/or nonclinical studies of a product candidate may not be predictive of success in subsequent clinical and/or nonclinical studies of that candidate; that the ongoing Israeli regional conflict may materially and adversely impact our manufacturing processes, including cell banking and product manufacturing for our cell therapy product candidates, all of which are conducted by our subsidiary in Jerusalem, Israel; that Lineage may not be able to manufacture sufficient clinical quantities of its product candidates in accordance with current good manufacturing practice; and those risks and uncertainties inherent in Lineage&#x2019;s business and other risks discussed in Lineage&#x2019;s filings with the Securities and Exchange Commission (SEC). Further information regarding these and other risks is included under the heading &#x201c;Risk Factors&#x201d; in Lineage&#x2019;s periodic reports with the SEC, including Lineage&#x2019;s most recent Annual Report on Form 10-K filed with the SEC and its other subsequent reports, which are available from the SEC&#x2019;s website. You are cautioned not to place undue reliance</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">on forward-looking statements, which speak only as of the date on which they were made. Lineage undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law. All forward-looking statements are expressly qualified in their entirety by these cautionary statements.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Lineage Cell Therapeutics, Inc. IR</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ioana C. Hone</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(</font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ir@lineagecell.com</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">)</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(442) 287-8963</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Russo Partners &#x2013; Media Relations</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Nic Johnson or David Schull</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(</font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Nic.johnson@russopartnersllc.com</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">)</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(</font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">David.schull@russopartnersllc.com</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">)</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(212) 845-4242</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">###</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img193828089_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img193828089_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %H!LP# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML::G&7<A5&Q^2?PKPFK.F_\ (4M/^NR?^A"@#Z0HHHH **** "BBB@ HHHH
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M/_VW_P#:= 'F=;/A[PU>>);B:&SE@C:%0S&9B 03CC -8U>A_";_ )"FH_\
M7%?_ $*@"K_PJK7?^?O3O^_C_P#Q%'_"JM=_Y^]._P"_C_\ Q%>P44 >/_\
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M4L(S@.1E3]&'!K.KZ2DBCFC:.5%=&&&5AD$>XK@_$GPVMKL/<Z.1;3]3 ?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %(>E+10!YQXF\(S)/)?6"&2-R6DA4<J>Y4=Q[5Q[*58JP((X(/:O=<
MC%4YM-LKLYN;."4_]-(PW\Q7I8?,ITH\LE<\G$99&I+F@['BM%>R?V#I'_0,
ML_\ ORO^%']@Z1_T#+/_ +\K_A6_]KK^5G/_ &3+^9'C=%>R?V#I'_0,L_\
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MK1HHKRFVW=GL12BK(6BBB@H**** "BBB@ HHHH **** /)/BO_R'K+_KU_\
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M:*** "BBB@ HHHH **** "O)/BO_ ,AZR_Z]?_9FKUNO)/BO_P AZR_Z]?\
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M:A_VVX_EN_,5;^*FE;+BSU5%X<&"0X[CE?TS^5=3X!TT:9X5MMRXEN?](?\
MX%]W_P = JYXMTO^V/#=[:JNZ4)YD6.N]>0/QZ?C0!X)7I?PJU3F]TEVZXN(
MA^0;_P!E_6O-*U/#NIG1_$%E?9PD<@$G^X>&_0F@#Z%HIH((!!R#T(IU !11
M10 4444 %%%% !1110 4444 %02S1P0O-*X2-%+,Q/  ZFIZ\[^)NNFULHM'
M@;$ER-\Q!Z(#P/Q(_3WH X7Q3X@E\1:R]R21;)\EO&?X5]?J>I_^M6)16EH6
MCSZ]J\%A!P7.7?'"*.K?Y[XH U/"'A.7Q%>&6;='I\)_>..KG^ZOOZ^E>UVE
MI;V-K';6L2Q0QC"(HX%5M.TZWTNPAL[2,)#$N%'KZD^YK1H **** "BBB@ H
MHHH **** .9\4>%K3Q':%6"Q7:#]S/MY'L?4?RKQ2]LKC3[V6UNHS'/$VUE/
M^>E?2-<'\0O#0U+33JEM'_I=JN7 ',D?<?4=?SH \BKTOX:>)>3H5TW&"UJQ
M/XE/ZC\:\TJ6VN);2YBN('*2Q,'1AV(Z4 ?2E%9>BZG'K.C6NH1XQ,@+*/X6
MZ,/P.:U* "BBB@ HHHH **** "BBB@#YY\1_\C1J_P#U^S?^AFLRM/Q'_P C
M1J__ %^S?^AFLR@#W?P+_P B9IO^XW_H;5T5<[X%_P"1,TW_ '&_]#:NBH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** /)/BO_R'K+_KU_\ 9FK@:[[XK_\
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MYY\1_P#(T:O_ -?LW_H9K,K3\1_\C1J__7[-_P"AFLR@#W?P+_R)FF_[C?\
MH;5T5<[X%_Y$S3?]QO\ T-JZ*@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@!.U%)FN3\1>,(M,D:UM46:Y'WB3\L?U]3[5=*E.K+E@KLRJUH4H\TW9'6T
ME>1S>*-;F<N;YT]%C 4#]*C_ .$FUK_H(S?I7H+*JO='GO-:79GL-%>/?\)-
MK7_01F_2C_A)M:_Z",WZ4_[*J_S(7]K4OY6>PT5X]_PDVM?]!&;]*/\ A)M:
M_P"@C-^E']E5?YD']K4OY6>PT5X]_P )-K7_ $$9OTH_X2;6O^@C-^E']E5?
MYD']K4OY6>PT5X]_PDVM?]!&;]*/^$FUK_H(S?I2_LJKW0?VM2_E9[#17CW_
M  DVL_\ 00F_,4Y/$VM1N&&H2DCLP!'Y$4?V75[H?]K4OY6>P4E<+H7C9;B5
M+74E6)VX69>%)]QV^O3Z5W"D'I7!6HSHRY9H[Z->%:/-!CZ***S-AN:6N7\0
M^*K?1AY,8$]V1G9G 4>I/]*XNX\5ZU<.6^V&(=DC4*!_6NRA@*U:/,M%YG#7
MQ]*C+E>K\CURBO'O^$FUK_H(S?I1_P )-K7_ $$9OTKH_LJK_,CG_M:E_*SV
M&BO'O^$FUK_H(S?I1_PDVM?]!&;]*/[*J_S(/[6I?RL]AHKQ[_A)M:_Z",WZ
M4?\ "3:U_P!!&;]*/[*J_P R#^UJ7\K/8:*\>_X2;6O^@C-^E'_"3:U_T$9O
MTH_LJK_,@_M:E_*SV&BO'O\ A)M:_P"@C-^E'_"3:U_T$9OTH_LJK_,@_M:E
M_*SU[%.KR$>*-;!&-0FR/7!_I6_HWCQS(L&J*NUC@3H,8_WA_4?E653+:U.-
MU9^AK2S&C.5G=>IZ#142.LBAE8,K#((.014M<!Z(4444 %%%% !1110 4444
M %%%% 'DGQ7_ .0]9?\ 7K_[,U<#7??%?_D/67_7K_[,U<#0!Z9\(^NL?]L/
M_:E>FUYE\(^NL?\ ;#_VI7IM !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %9?B3_D6-6_Z\IO_ $ UJ5E^)/\ D6-6_P"O*;_T T ?/56=-_Y"
MEI_UV3_T(56JSIO_ "%+3_KLG_H0H ^D**** "BBB@ HHHH **** "H;C_CU
MF_W#_*IJAN/^/6;_ '#_ "H ^;**** /I.W_ ./6'_<'\JFJ&W_X]8?]P?RJ
M:@#.U*P@U33YK*Y3=%,NUAW'H1[CK7A&MZ//H>JS6,XR4.4?'#J>C"OHBN1\
M9^&H_$.DEH5'VZW!:$_WO5#]?Y_C0!XI7J7P[\4?:8!HEX_[Z(9MF8_>4?P_
M4=O;Z5Y<RLC%64JP."",$&GV]Q+:W$=Q!(8Y8V#HZ]01T- 'TK17/>%]?B\1
MZ3'<+A;A/EGC'\+>OT/4?_6KH: "BBB@ HHHH *\D^*__(>LO^O7_P!F:O6Z
M\D^*_P#R'K+_ *]?_9FH X&O4?A+_P >NJ_[\?\ )J\NKU'X2_\ 'KJO^_'_
M ":@#TBBBB@ HHHH **** "BBB@ KS+XN=='_P"V_P#[3KTVO,OBYUT?_MO_
M .TZ /,Z]#^$W_(4U'_KBO\ Z%7GE>A_";_D*:C_ -<5_P#0J /5J*** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!C,$4LQ 4#
M))[5\]^(-3.L:]>7Y)*RR'9GL@X4?D!7K?CO5?[,\*7.QL37/[A.>?FZG_OG
M->)4 %>]>$=*_L?PU9VS+ME9/-E'?<W)'X<#\*\?\)Z5_;'B:RM67=$'\R7_
M '%Y/Y]/QKW^@ HHHH RM?TT:OH5Y8D#=+&0F>SCE3^8%?/C*R,58$,#@@]C
M7TQ7AGCS2_[+\67.U<17/^D)_P "Z_\ CP- &'IE])IFIVU]%]^"17 ]<'D?
MCTKZ'MYX[JVBN(6W1RH'1O4$9%?-U>R_#?5?M_AD6KMF6R?RSZ[#RI_F/PH
M[2BBB@ HHHH **** "BBB@ HHHH \S^*]YA--L0>I>9A^0'\VKS*NR^)MP9O
M%OE]H;=$_/+?^S5QM '??"NP$VLWE\PR+>$(O^\Q_P %/YUZW7"?"ZV$7AN>
MX(^::Y//L  /US7=T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 ?//B/_ )&C5_\ K]F_]#-9E:?B/_D:-7_Z_9O_
M $,UF4 >[^!?^1,TW_<;_P!#:NBKG? O_(F:;_N-_P"AM714 %%%% !1110
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MDTK%W=BS,>Y-1445]C!65D?'MWU84444P"BBB@ HHHH **** "BBB@ HHHH
M]#\!ZD]S92V4K$M;D%"?[A[?@0?S%=I7G/P]1CJ5VX^X(@#]2>/Y&O1>]?*X
MR"A7DD?48&;E0BV.HHHKE.T**** "BBB@ HHHH **** /)/BO_R'K+_KU_\
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MBN;=P\,JAT8=P:^;J]!^'/BC[)<#1+R3]Q*W^C,Q^XY_A^A[>_UH ]8HHHH
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M>JLZ;_R%+3_KLG_H0JM5G3?^0I:?]=D_]"% 'TA1110 4444 %%%% !1110
M5#<?\>LW^X?Y5-4-Q_QZS?[A_E0!\V4444 ?2=O_ ,>L/^X/Y5-4-O\ \>L/
M^X/Y5-0 4444 %<_XGT"'Q%I4EJ^%F7YH)"/N/\ X'H:Z"B@#YKNK::RNI;:
MXC,<T3%'4]B*C!*D$$@CD$5ZK\1?"WVRV.M6B?Z1"N+A0/OH/XOJ/Y?2O*:
M/:?!'B<:[IGDSL/M]L )<]77L_\ C[_6NPKYTTC5+G1=2AOK8_/&>5)X=>ZG
MV->\Z5J5OK&FPWMJV8I5R >JGN#[@T :5%%% !7DGQ7_ .0]9?\ 7K_[,U>M
MUY)\5_\ D/67_7K_ .S-0!P->H_"7_CUU7_?C_DU>75ZC\)?^/75?]^/^34
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MG2-2@\3:9++I]VB+<H69H6  SU)Q7NM% !1110 4444 %%%% !1110 4444
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MGX>U2VM[);<I)#O;S$).=Q'J/2N:_P"%H>(/[EE_WZ/_ ,55GXK_ /(>LO\
MKU_]F:N!H [7_A:'B#^Y9?\ ?H__ !5'_"T/$']RR_[]'_XJN*HH [7_ (6A
MX@_N67_?H_\ Q5'_  M#Q!_<LO\ OT?_ (JN*HH [7_A:'B#^Y9?]^C_ /%4
M?\+0\0?W++_OT?\ XJN*HH [>'XFZ\\T:%+/#, ?W1]?]ZO8J^:[;_CZA_WQ
M_.OI2@ HHHH **** "BBB@ HHHH ^>?$?_(T:O\ ]?LW_H9K,K3\1_\ (T:O
M_P!?LW_H9K,H MQ:5J-Q$LL-A=21MT=(6(/X@4_^Q-5_Z!E[_P" [?X5[3X%
M_P"1,TW_ '&_]#:NBH ^=/[$U7_H&7O_ (#M_A1_8FJ_] R]_P# =O\ "OHN
MB@#YT_L35?\ H&7O_@.W^%']B:K_ - R]_\  =O\*^BZ* /G3^Q-5_Z!E[_X
M#M_A1_8FJ_\ 0,O?_ =O\*^BZ* /G3^Q-5_Z!E[_ . [?X4?V)JO_0,O?_ =
MO\*^BZ* ///A=9W5E;ZFMU;30%GCVB5"N>&Z9KT.BB@ HHHH **** "BBB@
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M5%NIA_>C08_4@U'_ ,+"TO\ Y][S_OE/_BJV6%JO[+.9XNBOM(Z[=1NKDO\
MA8>E_P#/M>?]\I_\52_\+#TO_GVO/^^4_P#BJ/JM;^5A]<H_SHZS=1NKD_\
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MI67XD_Y%C5O^O*;_ - - 'SU5G3?^0I:?]=D_P#0A5:K.F_\A2T_Z[)_Z$*
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M.O3:\R^+G71_^V__ +3H \SKT/X3?\A34?\ KBO_ *%7GE>A_";_ )"FH_\
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M161N%%%% !1110 4444 %%%% 'DGQ7_Y#UE_UZ_^S-7 UWWQ7_Y#UE_UZ_\
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M\0?W++_OT?\ XJ@#V2BO&_\ A:'B#^Y9?]^C_P#%4?\ "T/$']RR_P"_1_\
MBJ /9**\;_X6AX@_N67_ 'Z/_P 51_PM#Q!_<LO^_1_^*H ]DHKQO_A:'B#^
MY9?]^C_\51_PM#Q!_<LO^_1_^*H ]DHKS#POXYUC6O$EII]TML(9=^[9&0>$
M9ASGU KT^@ HHHH **** "BBB@#E/'NJ#2_"USM;$US^X3_@7WO_ !W/Z5XC
M7=?%#5/M.NPZ>C9CM(\L/]MN?Y;?S-<+0!?T33FU?6K.P7/[Z4*Q'4+U8_@
M37T*D:QQK&@"HH 4#L!7EOPKTOS;^[U1U^6%?*C)_O-R?R _\>KU>@ HHHH
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M9VJ;(8EVJ/ZGWJ#1](L]"T]+*RCVHO+,?O.W<D]S6K0 4444 %%%% !1110
M4444 %%%% 'SSXC_ .1HU?\ Z_9O_0S696GXC_Y&C5_^OV;_ -#-9E 'N_@7
M_D3--_W&_P#0VKHJ\.TOQ]K&DZ;#86RVIAA!"[XR3R2>>?>KO_"T/$']RR_[
M]'_XJ@#V2BO&_P#A:'B#^Y9?]^C_ /%4?\+0\0?W++_OT?\ XJ@#V2BO&_\
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M!O#7_0*C_P"^W_QH \(HKW?_ (0;PU_T"H_^^W_QH_X0;PU_T"H_^^W_ ,:
M/"**]W_X0;PU_P! J/\ [[?_ !H_X0;PU_T"H_\ OM_\: /"**]W_P"$&\-?
M] J/_OM_\:/^$&\-?] J/_OM_P#&@#PBBO=_^$&\-?\ 0*C_ .^W_P :/^$&
M\-?] J/_ +[?_&@#PBO>_!O_ "*&E_\ 7$?S-1_\(-X:_P"@5'_WV_\ C6O9
MVD%C:1VUO&(X8QM1 2<#\: +=%%% !1110 4444 %9?B3_D6-6_Z\IO_ $ U
MJ56N((KBVEMY4WQ2H4=3W4C!'Y4 ?-]6=-_Y"EI_UV3_ -"%>W?\(-X:_P"@
M5'_WV_\ C21^"?#L4BR)ID8="&4[WX(_&@#HZ*** "BBB@ HHHH **** "H;
MC_CUF_W#_*IJ:RAU*L,@C!% 'S117N__  @WAK_H%1_]]O\ XT?\(-X:_P"@
M5'_WV_\ C0!N6_\ QZP_[@_E4U-50BA5& !@"G4 %%%% !1110 4444 %%%%
M !1110!B>(-%@U_2I;&? +?-')CE''0_Y[$UX5?V-QIM]-9W2;)H6*L/ZCVK
MZ0K'U#PUH^KW N+^PCFF"[=Y)!Q^!H ^?J]1^$O_ !ZZK_OQ_P FKIO^$&\-
M?] J/_OM_P#&KFF:)INBB5=.M5@$I!<!B<XZ=3[T :U%%% !1110 4444 %%
M%% !7F7Q<ZZ/_P!M_P#VG7IM96IZ'INM>5_:-HL_DYV;F(VYQGH?84 ?/=%>
M[_\ "#>&O^@5'_WV_P#C1_P@WAK_ *!4?_?;_P"- 'A%%>[_ /"#>&O^@5'_
M -]O_C1_P@WAK_H%1_\ ?;_XT >$45[O_P (-X:_Z!4?_?;_ .-'_"#>&O\
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M/M4__/>7_OLU'11[>?<?LH=B47=PI!$\H([AS6MIGB2XMW5+@F6$\%C]Y?\
M&L2D/%:4L55I2YE(QJX6G55FCTV*5)HEDC8,C#(([BIJY7PG=M)!+;.<A"&3
MZ'J/S_G759KZO#5E6I*:ZGS=>DZ51P?06BBBMS(**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[V;GCS%.]/Q[C\C7<PS17$*S02))$XRKHP((]B*\B\1?#R^TF)[JQ<WMLO+
M+B1![CN/I^59GA;Q;>>&[H %I;)V_>P$_JOH?YT >\456LKVWU"RBN[60202
MKN1AW%6: "BBB@ HHHH **** "BBB@ HHHH **** "N$\6>.;GPYK*V,-E#,
MIB63<[$'DG_"N[KQOXH?\C8G_7JG\VH ]*\-:M)KGA^UU&6)8GFWY13D##E?
MZ5M5S'P]_P"1(T__ +:_^C7KIZ "BBB@#!\5:Y)X?T5K^*%)F$BIM<D#FL7P
MAXWN?$FK2V<UG%"J0&4,C$DD,HQS_O58^)7_ ")\G_7:/^=<?\*O^1HN?^O)
MO_0TH ]@HHHH **** "BBB@ HHHH *P?%6N2>']%:_BA29A(J;7) YK>K,UC
M1[37+ V5X',)8,0C8.10!YY_PMB^_P"@;;?]]M1_PMB^_P"@;;?]]M73?\*T
M\._\\[G_ +_&C_A6GAW_ )YW/_?XT <S_P +8OO^@;;?]]M1_P +8OO^@;;?
M]]M6]>?#GP_!97$B1W&Y(V9<S'J!7E&FP)=:K9V\F?+EG1&P<<%@#0!W/_"V
M+[_H&VW_ 'VU'_"V+[_H&VW_ 'VU=-_PK3P[_P \[G_O\:/^%:>'?^>=S_W^
M- ',_P#"V+[_ *!MM_WVU>BZ/?-J6C6=\Z!&GB60J#P,BL#_ (5IX=_YYW/_
M '^-=+96<6GV,-G "(H4"("<G H MT444 %>:ZQ\2KS3-9O+%-/@=8)6C#%S
MDX->E5\_>*_^1LU7_KZ?^= 'NMA.;S3K6Y90K31)(0.V0#5RJ&B?\@'3O^O6
M+_T$5?H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M$?\ S]2?]\BNCR:,FCZAA_Y0^O8C^;\CG/\ A$(_^?J3_OD4?\(A'_S]2?\
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M\;?V%H.G6-@%:_:TB+,PR(04&..Y]JXN/2O$OB>7[4+>[O"W260X7\"V!^5
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.1D5X3XYTY=-\77L<:[8Y2)E'^\,G]<UZUX1O6U#PKIUPQ)8PA"3W*DJ3^E
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M ZF=/,8J#RJG;U^N/TH Z#X=ZF^H>%8TE;<]K(8,GNH *_H<?A785YY\)O\
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M,G\N!^%=!0 5GZGI=EK%F]K?0K+$WKU4^H/8UH44 > >(M#N/#6L&W+L8_\
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M_P @'3O^O6+_ -!%7Z "BBB@#E_&WB!M T)FA;%Y<'RX?]GU;\!^I%>4>&M
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MT% %JBBB@ KQOXH?\C8G_7JG\VKV2O&_BA_R-B?]>J?S:@#O?A[_ ,B1I_\
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M05)_PLOQ'_SUM_\ OR*])T[0]"N]+M+D:-IQ\V%),_94YRH/I5S_ (1O0O\
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MJ/\ UV7_ -!KT.@ HHHH R_$G_(L:M_UY3?^@&O%_!L7G>,-+7&<3!OR!/\
M2O:/$G_(L:M_UY3?^@&O$O"LRV_BO2Y&X'VE%)^IQ_6@#Z!HHHH **** /+O
MBU$!=:7-CEDD7/T*G^M:GPI<GP]>)V%V2/Q1?\*QOBQ.K:GIUN#\R0LY^C-C
M_P!E-;7PLC:/PW<2'I)=-CZ!5_\ K_E0!WE%%% !7SEJ\AEUJ^D;[SW$C'\6
M-?1M?.NMPFVU[483G]W<R+S[,: .@'Q*\0@ "2V '  A%+_PLOQ'_P ];?\
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MX=F472!H6.(YXSE6/I['V-=S\//%<VH[M)U"7S)HTWP2L<EE'53ZD=<_7TH
M]&HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^PK5\RN0UR1_"O4+]3P?I]:K^(?B<K1O;:(C G(-U(N,?[J_U/Y5Q6D:/?\
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MH **** "BBB@"KJ7_(,N_P#KB_\ Z":^?M$_Y#VG?]?47_H0KZ!U+_D&7?\
MUQ?_ -!-?/VB?\A[3O\ KZB_]"% 'T71110 4444 %%%% !7S]XK_P"1LU7_
M *^G_G7T#7S]XK_Y&S5?^OI_YT >Y:)_R =._P"O6+_T$5?JAHG_ " =._Z]
M8O\ T$5?H **** /GGQ'_P C1J__ %^S?^AFO?--_P"09:?]<4_]!%>!^(_^
M1HU?_K]F_P#0S7OFF_\ (,M/^N*?^@B@"U1110 5XU\3-,:T\2"]5?W5Y&&S
MVWJ-I'Y;3^->RUSOBK04\1:3)9Y"SJ?,@<_PN/7V/3_]5 &=\.=834/#RV;-
M_I%D?+8'J4/*G^GX5V=?/FG:AJ/AC7/-5&BN86*2POT8=U/M_P#6->LZ-XVT
MC68D N$MKD]8)F"G/L3PWX<^U '544T$$ @Y!Z$5DZMXCTO18F>]O(U<=(E.
MYV^BCF@"Q?ZG9Z7"DU]<QV\;N$5G. 6/;]#5BWN(+J(2V\T<T9Z/&P8'\17A
MOBGQ%<>)=0$C*8[6+(@ASG ]3[FO0?AYX>ET?2Y+NZ4I=7>#Y9&"B#H#[G.?
MRH [FBBB@ K!\9?\BAJG_7$_S%;U8/C+_D4-4_ZXG^8H \O^'/\ R.EI_N2?
M^@&O;J\1^'/_ ".EI_N2?^@&O;J "BBB@ HHHH \\^*Q;^R-/ SM,Y)^NWC^
MM4?A/&ADU24X,BB)1[*=V?U _*NG\=Z1)K'AN6.!"]Q;L)XU'5L9! _ G]*\
MM\*^(G\-ZL+@JTEM(NR9%ZE?4>X_QH ]\HK,TW6M.UB 2V%W',",E0?F7ZCJ
M*OLRHI9B%4<DDX H DKR#XHZFEUKEO8QMG[)&=_LSX)'Y!:Z?Q'X^T_2K=X-
M-F6[OCP"AS''[D]#]!^E>7WMC>?V?%K%V6/VV9]I?J^,$M^9Q^!H ]%^$W_(
M+U'_ *[+_P"@UZ'7GGPF_P"07J/_ %V7_P!!KT.@ HHHH R_$G_(L:M_UY3?
M^@&OGQ':.19$)5U(*D=B*^@_$G_(L:M_UY3?^@&O"]!L$U76[6PD8JL[%-P[
M9!P: /=-%U2/6-&M;^+&)4!8#^%NC#\#FM2O&/#OB"[\$ZO<Z9J,3M:^9B5!
MU1NSKZ@C'U&*]6T[5]/U6$2V-W%.I&<*W(^HZC\: -&D)P,FH+BX@M8C+<31
MPQCJ\C!0/Q->:^,_'D-Q;2:9I$A99!MFN1P"O=5^OK0!RGB_5UUKQ-=W4;;H
M%/E1'/!5>,CZG)_&O7O"&FG2_"UA;.,2%/,<'J&8[L?AG'X5YAX&\-/KFKK/
M-&?L%LP:0D<.W4)_C[?6O;J "BBB@ KQ/XC:8UCXIDN N(KQ!*I[;APP_,9_
M&O;*YCQ9X='B+1GA7 NH3O@8_P![NI]C_AZ4 5_ &KIJGAN&%GS<68$,@[X'
MW3^7'X&NOKY]TK5-1\+:R9%1DEC/ESP2# 8=U/\ C7KFC>,=(UN)?+ND@N"/
MF@F8*P/MGAOPH Z:BD!R,BL/6/$6DZ+"S7=XGF <0HP:1OP_QXH NW^JV&EK
M&U]=16ZRML0R' )QFK$$\-S$LL$J2QMT>-@P/XBO"/$GB&Y\1:EYTBE(4^6"
M$'.P?U)[FO3? 7AV70](:2Z4K=79#NA_@4?=7Z\DGZX[4 =E1110 5SWC> W
M'@S4T Y$8?\ [Y8-_2NAJO<01W5M+;RKNCE0HX]01@T >)>!+Y+'QA9-(0$E
M)A)]V&!^N*]UKYVUC2KG1-7GL9P0\3?*_3<O9A]:]$\+_$6TGMH[36)/(N4
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MY\8#X.=J^V>I]J;\,M#DN=5;5Y$(M[8%8R?XI",<?0$_F* /7**** "BBB@
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MF9XO_8NJ?] R\_[\/_A1_8NJ?] R\_[\/_A7M&!1@4?VM5_E0?V3#^9GB_\
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M/1;=\?H*MV7@;Q%>N NFR0KW:<B,#\#S^E>[T4 <+X;^'MKH[I=W[K=WBG*
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M0 4444 9?B3_ )%C5O\ KRF_] ->+^#?^1PTO_KL/Y&O:/$G_(L:M_UY3?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!E^)/\ D6-6_P"O*;_T UXOX-_Y'#2_^NP_D:]K
MU:U>_P!&O;.-@KW%O)$K-T!92!G\ZX70OASJ.DZW9W\MY:O'!)O94W9/TXH
M]+HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
<@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>lctx-20250826.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-08-25T17:14:04.7651+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://lineagecell.com/20250826" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:lctx="http://lineagecell.com/20250826" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" namespace="http://fasb.org/us-gaap/2025"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" namespace="http://xbrl.sec.gov/dei/2025"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://lineagecell.com/20250826/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:roleRef roleURI="http://lineagecell.com/20250826/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="lctx-20250826.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://lineagecell.com/20250826/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10010.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10130.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10020.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10000.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10090.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10100.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10120.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10110.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10040.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10050.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10060.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10070.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10030.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10080.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10140.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10190.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10180.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10210.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10340.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10170.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10220.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10160.0" priority="2" use="optional"/>
        </link:presentationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Aug. 26, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 26,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Lineage Cell Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000876343<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-12830<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-3127919<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2173 Salk Avenue, Suite 200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Carlsbad<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92008<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(442)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">287-8990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common shares<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LCTX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSEAMER<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="lctx-20250826.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lineagecell.com/20250826/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="lctx-20250826.htm">lctx-20250826.htm</File>
    <File>lctx-20250826.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>12
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "lctx-20250826.htm": {
   "nsprefix": "lctx",
   "nsuri": "http://lineagecell.com/20250826",
   "dts": {
    "inline": {
     "local": [
      "lctx-20250826.htm"
     ]
    },
    "schema": {
     "local": [
      "lctx-20250826.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://lineagecell.com/20250826/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_405e5aab-2417-4f78-a579-0c21252efeec",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "h2",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lctx-20250826.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_405e5aab-2417-4f78-a579-0c21252efeec",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "h2",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lctx-20250826.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://lineagecell.com/20250826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://lineagecell.com/20250826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://lineagecell.com/20250826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://lineagecell.com/20250826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://lineagecell.com/20250826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://lineagecell.com/20250826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://lineagecell.com/20250826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://lineagecell.com/20250826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://lineagecell.com/20250826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://lineagecell.com/20250826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://lineagecell.com/20250826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://lineagecell.com/20250826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://lineagecell.com/20250826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://lineagecell.com/20250826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://lineagecell.com/20250826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://lineagecell.com/20250826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://lineagecell.com/20250826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://lineagecell.com/20250826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://lineagecell.com/20250826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://lineagecell.com/20250826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://lineagecell.com/20250826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://lineagecell.com/20250826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>13
<FILENAME>0000950170-25-111319-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-25-111319-xbrl.zip
M4$L#!!0    ( ,%)&EOB"TRDDA8  -V]   1    ;&-T>"TR,#(U,#@R-BYH
M=&WM/6M3XSBVW^=7:)F[,W1=E/C]"'1O,8&>S9UNFB),S=S[94NVY,33CIWU
M@Y#]]?<<V<Z+T D00FA"53?8UN/HZ+QU))W\XW80D1N19F$2O_]9;2@_$Q'[
M"0_CWON?3[OM3N?G?WSXX>1OE)*SCYT+<B%&Y-3/PQMQ%F9^E&1%*LAA]_,[
MTHFC,!;DSU^N/I&SQ"\&(LX))?T\'[::S=%HU.!!&&=)5.305];PDT&34%HU
MWDX%P_?DC.6"M#1%,ZGB4,V\5NV6:K04HV$HJO+?BM)2E)EJR7"<AKU^3@[]
M=P1K0=]Q+*)(C,G',&:Q'[*(=.M>CP!,OT%.HXA<8;6,7(E,I#>"-\I&^SG@
M W 29^\/9D ?Z8TD[355UW6;MUCFH"S4NO72B(>3LO@H2VJ*8C7+CW-%\Z5%
MS;)H/ELTG -@MK3>!#SF,#11EP?,?_U&<?SLL6Q2_/9.^;GQX=>Z:'A[7[LJ
M@H%3CC->%X^3^ )F/@W]Y=5XGC;S\5 TH2"-RY(3J+)P&4PP K7YY^=/7;\O
M!HPN#IV+!>QGPF_TDILF?&@B04QPY.?3L2#<K"=\(!1)B%A0<31K.NR<0D-S
M\-0-3T?=S%,69T&2#B3M(E(DU>KJ3#O+$?&M1C2-*AI5K8,//Y"3OF <?I.3
M/,PC\<&AOYTTRS_QY4#D3+(8%?\NPIOW!^TDSH'QZ#4@^8#XY=/[@US<YDU)
MMTULM%FU>N(E?$RR?!R)]P=#QI'M6\[P]GC TEX8MUB1)W\+!\,D!9SGQ_\!
M['-QVU*.Z4AX7\.<8KLT"_\C*.-_%5G>4A7E[\?#) MQ+*U41 QEQ?&!A):'
M-W5G/,R&$1LCP>#7D_"VA3")M/PSY%S$\L\I19&0OS_X^"^#NZ9C.RHU3=>F
MANL8U&.F15VF>@'3F"W4X(#$;("]B+!U'@.ZQFU 0\JB#L+_FQA7J+G-KT0
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M^N9664^:7L+''WXX:?;S0?3A_P%02P,$%     @ P4D:6W, \:YJ"   2ET
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MS'=UPQN)K^\&=X*O_Y[_#U!+ P04    " #!21I;9PC)OH(5  "E>@  #@
M &QC='@M97@Y7S$N:'1M[5U;=]M&DG[/K^AQ-C/V68*B;KZ02DYD28XU420?
M23/)/.UI DVB+0"-= .BF%^_7U4#!"2!<3:6+69-G\26<>FNJJ[[!=[[6Q"(
MPS?'IV(_+/2U.M0N3(PKK1)/+WYZ)MY>_G0B#DU8IBHK1"#BHLB'&QNSV:P?
M373F3%(6VF2N'YIT0P3!=WNTX(%5DBZ+0UDH,=P:;.T&@Y?!UN[EYHOAYLYP
ML-/?V=S9_>_!8#@8-&^9?&[U-"[$T_"9H)>P<Y:I)%%S\49G,@NU3,1%O6=/
M'&=A7^PGB3BGUYPX5T[9:Q7U:<VO]N(B3;[[2NS%2D;X4^P5NDC4=T>_!*_Z
MFWL;_F^XOU$]L#<VT5RX8IZH;Y_D,HIT-AV^S&]&J;13G0UE69B_Z30WMI!9
M,?HMT%FD;H:#43!3XRM=!(6Z*0*G?U.!C-Z7KAAN#@;?C'+C- $\M"J11.31
M$X8FTM=W-@L*DP\'_5V=+1;?&J4Z"V)%".+6"[IW?\&QN:%]"=ZQL9&R :Y@
MF[V\WF%B,@\:8,J+"B._WXCO362JD_GP4J?*B5,U$^<FE5G]X-@4A4GQ+*,H
M$SW-AB%80MGZB41- &#]-^OA)1!H]1J*6:P+%;A<AFJ86Q7,K,Q'+= V 5H;
MFG\<8*NQU?_H.9FY *>K)_Z!*V4S0C<SF6(2S714Q,,)3B'$?8"&O?_^]>;S
MP6AO@][X;F\CQ_\@^H+X82*=^_9)*O%Z]1+_B;\K^Z2&N3Z)W<Z#_!P4QBXZ
MG0IGPV^?X(?-5]LOMUX.7K[ZGT'_?3Y](F12=-^HJ<ZDV1Z\ "M7G/1\.V?^
M()I\'@P^A@WN;O@Q'/#YL>7%KJ754!I#E\HD"4*9NU%H$F.'7P_XUV@Y36;^
MR,8FB=I$VGHP(IT<GQ[M_W D]D]/S_YU>G!T(<Z/+H[VSP_>BH.SDY/]UV?G
M^Y?'9Z?BY^/+M_CMY.1X_R=Q>/33_NFE.#[]]]'%I;@\PX5_'YV<O:.7ST[W
ML4Y-]C8Q_@S2U\H6.I1)1657YB!R0XD7_>T7#\DPN]NC+L@?\A@_@-'+_F!G
MT/KU</(@/C5FGX1!G^Z?OMM\)MZ<G8NWX,OCTQ_$R=G%Q5\2%_&XRN@Q56_+
MY@*(-$BT*P*5*/(M&9"\97;;;L5V?WM[^YM1I%V>R/EPDJB;VR0B9TM/YO7N
M_$3@"FF+$1,CH/W<<"R=2C3!?(=L#0[55BTZ5FO?)>0?92@FZVY_]R/HNMW?
MV7GQ:O,57.;-P?/M5R^^&<W@Y05CN-E7PRNE<H":+,BC,\(Q8"K]#F'HA&ZV
M=L/)XHQ:#NGMM?XL[DN$Z>%X[#*V2@5S):T KZ="TXU(1:(P0D;7B!B4 $@A
MD"!U*R)UK1*3<S!C)H@7+DS&#RW8E/S#ZO<UNZ[9]6'9]5\Y,>9_;6X)+)10
M@ PF;/-D:!S"6#PS5H)>LWI<%F#G\5S\3&_(5!PJ[%D@]+U6KNABV[R+)9_W
MGS_'.7P",[.$W_Z_NOAK=%=*H@[VST\N7N\?]L3!OB %,=C<'HG]<@JXQ=;S
MGD\C?4P@\M 0![>@>2PN.H&:E%,E#E22B,M882-5(B2IDFH+]EI.M]WGV^%F
M-]V8?R(5&LM9P&$)DVQ),0MG$OV).&&E#OGIZ7\N$$^GRL+MR(3,(G&Y?W$T
M%"<'E[\\ZPDI:I>$K!O.8:Q-H<(X [S3.51_FLML7IL&;"<R@Q\%[*:9JDSI
ML">,K1@^')G)1!0QR!NK9.(O1J.>".EP"SY<#40F>(,R:*9T(E.EI;W8*R+P
M3!X7L4Q2'9+AB72582U,).=X(#,EW"3X5;$LA"Y$+)W@^ +7X'3!VQ)6.?AA
M88SWDT2.J\,7,UW$O$,16U-.Z6>\0<:++-[#']I'I@Q7BHTFUJ2K3:''TE^=
MWI#8W[CX YKK<Y^B>/KSX?&SOL#O0COB?XBUG2)RJ24!@NDE1(D8II+DO58!
M)+1WD'T#68Q8N+RHOQJYED0)284<R"^@#2"6J7QOK"[F4 [2*EI>67([:3.X
MY4D$!U'REC'$M_HS*>(03]=0].JM0>#^2I%V[?:MHMOW\&$^PG@$@<33,PB#
M>&]@=)+Y(L:OW)E&'F0)$V;LW!NZ#$;.&T,+C8=(,2MZK>#?IQ=[+&LD%@65
M+^L<02T5B7&N3ZZ22,NDT#[IL,3FA3#6UBW-/#02VH/@ADGI)9X !%W*">Z7
MM&</*Q@S"? ?:!&JG X"#]-[C$G"V\ED8P+K['\4J8E4@@?PNP84\_;.<!K*
M C(-')2D(B^>LVI:8AVBE<.BA9I"W$D;@3VN%(#%HG.GV1<0KLRI^@FUDALZ
M&ZK''I\>;AQ<[HN)!JY3K^;XD !4),I[(:_.EI.-HE^B'1]#3KY*U/,>1#?]
M%HQ /DL94JCL0<_ #1PVUXXN77:A)IAI$[*LXLCJ*P>-F'+AF $ZP -6]9C;
MZ/3/X!,#,N@]P!%K/$$:''08.QUI":)5JK12D#_ Q\D_7D,^7+KY =3U ^:^
MU_KZB]#7=5S2J%A(C2DM=(2%FT996@NUDLR#2JPAJW?T,ZF^J8730X(;ZVF<
M^!8/DC4UF6@2Y7#.=RFO"!A($FF/5AR%E0HH];0OSDBI0&YCTEY>L;#D D5>
MPT<IK#P90$VJC;6SY7PO]%SC8D$5J-KT>*^-# A!3#I(U+JZ#GA<&8;*N4G9
M5N^J5AS84-L%_O,<RH<B/-+$$:S7C*F5) HO 0CL >B+2D4O8. 0K(+ZEMDI
M ++7RH1@$>,<6LJW2C"2[F6%"-5=JSD*\"19! /3Q ?F"=/A)7IR *-"7M$=
MPBH#;^)ME=,K'LU;F7>&1-V$FJ!K* >D-%Q;1886#Y 6!BE<K'-O4BC^G8F2
M4Z0$U)3(Y/WFEIEN4%0W1"WMF-I+U;T_?5KEEOEE$M]ERULKTBNU@2D4F!5@
MX0$(G0>J,9)X6(I(3R:@(UTI[G.\/]*ZQ\13R ?O/@JHC[?+I>C503]HSFN_
MI@*H."BI=ZJW@/'@Z*R_UL!?@@;>#T-CV:T$2Q(K_DRAGGC+0BO.[%1F^C?O
M=3W]^>T9G%]PB(4CM=7?%>/*4\N5R1,OVL3V[%YY#H<"5:36'?F2D:)8]JZO
M3,X7)5_A8<IL2E=9Q0 O7H0TK1=>0^(_H9BVCSA>. J.%0XCJ"]#+3AV>6/5
MY*8@JG-2R2:Y5GX_$K'&Z[>X3 *&]Q92"/3J6)<R5K="A%P6L3<G#L>I)Y2W
M*Q8(:83!VI*DK</?M3!_[F-^6W&A14B')<#\DA.YBIF>K*SSB5F\0IU%$$L2
MFYF$PU+;7["O]Q(4N1*6#0AQNB0)\29?>JM%X5DBYSY\ZI*H6J6,K=197^QW
MR!$'26$,D5->]FM!BK3C_E0"R^_*P'7M0N!$,N5 #N8/,@X3B;@U\SZ&+"J%
MD*8EV4-6"K3[#(J!50V[BM09T *7( ,,MLP+:A,^*"W9XX3\J0XTX/OA'7:$
M6DJAQDL1$O0:.YO>?+=2!SFGT!F-1*>:]WMK9J3>$(=G[32#S*'KI \N"?F
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MG06*[9V6N:HED1L/>>IK=/L&R.XOYW"\?%]C(">%LD.9P/UTZP&OQS_4O\2
MUXI91J="RDRS$W^3+PS?TKZ 6E?SDT9$""(*Q6EVZ1/<NJ!6(W+QN>J(9Q \
M63!5$*F))F,2RM*IM1^_]N,?WQ_V?OS2*L$CD>FQ>./#=%@AB:UJ17<K]M)W
M.''6U^><.G095UVJEUN5?"P@IE3-I^LM7[RA"R5K3)KJHLJ+I[[\56>$?(U&
M.VX&\9TK596I*0M12T6368*'7>=.X&$$4(Q6C%4&3>D#@_O M\%1V13>"#](
M(_SJ=G-%M7U##P8U!%VHY7-1,-,9F*^H9OHI=S2F'>E97_@B3WRJ*#'5NTT)
M.4Z\?J>D%O7(4+D2"'GX>7!_L8F;P_Q.B22^\Q31%LA,M4[RKCA-I+-?2VWG
M=3@SMH9/L%6[Y+1?,5\MR[$V'5^RZ?B#3?4KB<%C<^YCB>S2,ZMJ&'^F3;_7
M;LP/H+\";LQOBO1W&O-Y6#&RE"$OLQ3N<JHBMAZ94A'4\+WNQJHWQA<7?*V
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MZY-G9#_0WB2.S_\BE'IHPAP;F4EQ0..]V6.U"3\V#9ZN0EU-V^]7OTCY;)6
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M+FAT;5!+ 0(4 Q0    ( ,%)&EMS /&N:@@  $I=   1              "
M <$6  !L8W1X+3(P,C4P.#(V+GAS9%!+ 0(4 Q0    ( ,%)&EMG",F^@A4
M *5Z   .              "  5H?  !L8W1X+65X.5\Q+FAT;5!+!08
. P # +H    (-0     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>lctx-20250826_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lctx-20250826.xsd" xlink:type="simple"/>
    <context id="C_405e5aab-2417-4f78-a579-0c21252efeec">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000876343</identifier>
        </entity>
        <period>
            <startDate>2025-08-26</startDate>
            <endDate>2025-08-26</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec"
      id="F_4d958781-5597-4984-ba56-9a1bfa2a7e1f">0000876343</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec"
      id="F_2018aa5c-dfc3-4ce8-b376-d6895b3ce2b5">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec"
      id="F_d2516ab7-d089-495e-9ab4-12b2147e6ada">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec"
      id="F_84edddb2-57bc-46e3-9358-ddf8410c48ba">2025-08-26</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec"
      id="F_229ea4a3-a296-4427-bffa-750226ceb100">Lineage Cell Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec"
      id="F_27d43ffc-ca2e-4670-ba03-11d0ce6eec2e">CA</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec"
      id="F_20f5b682-7e38-4dce-8858-3c55eb593ad2">001-12830</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec"
      id="F_b18faed1-b11d-4c33-b580-86df6978c488">94-3127919</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec"
      id="F_f6bb2d38-fc7d-4f8d-87ee-961734a1d6f7">2173 Salk Avenue, Suite 200</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec"
      id="F_ac8c7c64-6166-4a2b-b215-0fdacbe8a3b2">Carlsbad</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec"
      id="F_f8b87063-b235-4ac2-9882-5d710fccd451">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec"
      id="F_c3d24d27-79f0-41ad-89ae-29bd0cc116c8">92008</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec"
      id="F_137c8332-f621-4e77-8b73-96b9988bf605">(442)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec"
      id="F_14865e5a-f414-40eb-a22d-3d814b0249bd">287-8990</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec"
      id="F_ad51223d-386c-46d1-8518-d55ced04fa03">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec"
      id="F_a67c4072-f7db-4a4a-a3a4-a1e85fd75fdb">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec"
      id="F_f00e07f0-0d76-49f8-8023-093c045f0295">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec"
      id="F_39aec429-baa1-4ecf-b8df-d005e445f063">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec"
      id="F_88736698-20be-4168-b0d0-c8cf41041626">Common shares</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec"
      id="F_6f6fd0a8-fced-4212-8d0f-9b8f273d181a">LCTX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec"
      id="F_98659eb3-d40e-4766-a92f-e63ff5c02dad">NYSEAMER</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_405e5aab-2417-4f78-a579-0c21252efeec"
      id="F_1c638b3c-f504-4fec-a1d7-607f2e175769">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
